RESIST – Research to help the most vulnerable

Our goal: a better protection of particularly susceptible people from infections

Viruses and bacteria shall no longer harm people, who are particularly susceptible to infections. This is the goal of the RESIST team. RESIST aims to pave the way to better prevention, diagnosis and therapy – for example for newborn babies, the elderly, people with congenital immunodeficiency as well as those whose immune system is suppressed for therapeutic reasons. Part of RESIST are physicians who perform clinical work and who are very familiar with the situation of the patients, but also researchers who perform basic research in the lab. The acronym of the Cluster of Excellence RESIST stands for “Resolving Infection Susceptebility”.

RESIST in figures

RESIST consists of more than 50 research groups from six different partner institutions (MHH, HZI, TWINCORE, TiHo, CSSB and CCI) working on 23 projects, focusing on the human immune system and genetics, but also on a dozen pathogenic viruses and bacteria. The speaker of the Cluster of Excellence is Professor Dr. Thomas Schulz, Director of the Institute of Virology at Hannover Medical School (MHH). The Deutsche Forschungsgemeinschaft (DFG) is funding RESIST under the Germany’s Excellence Strategy from 2019 to 2025 with around 32 million euros. Current information is available at: www.RESIST-cluster.de/en.